Focal Therapy for Prostate Cancer: A More Vehement View of the Approach Could Translate into Real Benefits for Our Patients.

Journal Article (Editorial)

The literature on focal therapy is currently insufficient to recommend it as first-line treatment. We need information from both randomised controlled trials and prospective registries for every available energy. That said, important research is under way in this field, and the door should be kept open to an approach that has the potential to offer adequate cancer control with lower morbidity and better post-treatment quality of life in properly selected patients.

Full Text

Duke Authors

Cited Authors

  • Sanchez-Salas, R; de la Rosette, J; Polascik, TJ; Carneiro, A; Sivaraman, A; Cathelineau, X; Walz, J

Published Date

  • November 2018

Published In

Volume / Issue

  • 74 / 5

Start / End Page

  • 537 - 539

PubMed ID

  • 29724502

Electronic International Standard Serial Number (EISSN)

  • 1873-7560

Digital Object Identifier (DOI)

  • 10.1016/j.eururo.2018.04.018


  • eng

Conference Location

  • Switzerland